Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy-Reference-Cited by-同舟云学术

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

Published:2008-12-21 Issue:1 Volume:27 Page:77-83
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Du Jinyan,Bernasconi Paula,Clauser Karl R,Mani D R,Finn Stephen P,Beroukhim Rameen,Burns Melissa,Julian Bina,Peng Xiao P,Hieronymus Haley,Maglathlin Rebecca L,Lewis Timothy A,Liau Linda M,Nghiemphu Phioanh,Mellinghoff Ingo K,Louis David N,Loda Massimo,Carr Steven A,Kung Andrew L,Golub Todd R

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.1513.pdf

Reference28 articles.

1. Simon, M.P. et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15, 95–98 (1997).

2. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. USA 104, 20007–20012 (2007).

3. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A. & Grosveld, G. Structural organization of the bcr gene and its role in the Ph' translocation. Nature 315, 758–761 (1985).

4. Tuveson, D.A. et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene 20, 5054–5058 (2001).

5. Smolen, G.A. et al. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc. Natl. Acad. Sci. USA 103, 2316–2321 (2006).

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma;Translational Research;2024-10

2. Drivergene.net: A Cytoscape app for the identification of driver nodes of large-scale complex networks and case studies in discovery of drug target genes;Computers in Biology and Medicine;2024-09

3. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models;Neuro-Oncology;2024-03-20

4. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment;Drug Development Research;2024-02

5. NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma;Life Science Alliance;2023-10-25